Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018)
The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) has collected data since 2012 in all six Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates). We report the relationship of PTH with mortality in this largest GCC cohort...
Gespeichert in:
Veröffentlicht in: | Kidney360 2020-10, Vol.1 (10), p.1083-1090 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1090 |
---|---|
container_issue | 10 |
container_start_page | 1083 |
container_title | Kidney360 |
container_volume | 1 |
creator | Al Salmi, Issa Bieber, Brian Al Rukhaimi, Mona AlSahow, Ali Shaheen, Faissal Al-Ghamdi, Saeed M G Al Wakeel, Jamal Al Ali, Fadwa Al-Aradi, Ali Hejaili, Fayez Al Maimani, Yacoub Al Fouly, Essam Robinson, Bruce M Pisoni, Ronald L |
description | The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) has collected data since 2012 in all six Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates). We report the relationship of PTH with mortality in this largest GCC cohort of patients on hemodialysis studied to date.
Data were from randomly selected national samples of hemodialysis facilities in GCC-DOPPS phases 5 and 6 (2012-2018). PTH descriptive findings and case mix-adjusted PTH/mortality Cox regression analyses were based on 1825 and 1422 randomly selected patients on hemodialysis, respectively.
Mean patient age was 55 years (median dialysis vintage, 2.1 years). Median PTH ranged from 259 pg/ml (UAE) to 437 pg/ml (Kuwait), with 22% having PTH 700 pg/ml. Patients with PTH >700 pg/ml were younger; on dialysis longer; less likely to be diabetic; have urine >200 ml/d; be prescribed 3.5 mEq/L dialysate calcium; had higher mean serum creatinine and phosphate levels; lower white blood cell counts; and more likely to be prescribed cinacalcet, phosphate binders, or IV vitamin D. A U-shaped PTH/mortality relationship was observed with more than two- and 1.5-fold higher adjusted HR of death at PTH >700 pg/ml and |
doi_str_mv | 10.34067/KID.0000772020 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8815498</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2646944853</sourcerecordid><originalsourceid>FETCH-LOGICAL-c393t-a2f989421bc3bfdb9ec0e8aa45e90a13792c58d28a0e6a0d79ad1d2171424be43</originalsourceid><addsrcrecordid>eNpVkU1v1DAQhiMEolXpmRvysRzS-iuJzQEJbaFbsagrCmdrEk-6Rk68tZNK-0_4uVjbT3zwjDTv-9qjpyjeM3oqJK2bs--X56c0n6bhlNNXxSGvJSubuqKvX_QHxXFKf7KMa86VqN8WB6IStWoafVj8XUOEabOLwVmyDHEII5JrjPNAVniHPhEYLfkR4gTeTTsCWXBDljgE68DvkktkDZPDcUrEjWTaILmYfU8WIWwxJ7sw5n4eO-f3dYoO0yfyE9Pss6WPYdibzq_W62tywinjZb7Ux3fFmx58wuOHelT8_vb112JZrq4uLhdfVmUntJhK4L1WWnLWdqLtbauxo6gAZIWaAhON5l2lLFdAsQZqGw2WWc4aJrlsUYqj4vN97nZuB7Rd3iSCN9voBog7E8CZ_yej25ibcGeUYpXUKgecPATEcDtjmszgUofew4hhTiZzqLWUqhJZenYv7WJIKWL_9AyjZo_UZKTmGWl2fHj5uyf9I0DxD9uGnaI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2646944853</pqid></control><display><type>article</type><title>Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018)</title><source>PubMed (Medline)</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><creator>Al Salmi, Issa ; Bieber, Brian ; Al Rukhaimi, Mona ; AlSahow, Ali ; Shaheen, Faissal ; Al-Ghamdi, Saeed M G ; Al Wakeel, Jamal ; Al Ali, Fadwa ; Al-Aradi, Ali ; Hejaili, Fayez Al ; Maimani, Yacoub Al ; Fouly, Essam ; Robinson, Bruce M ; Pisoni, Ronald L</creator><creatorcontrib>Al Salmi, Issa ; Bieber, Brian ; Al Rukhaimi, Mona ; AlSahow, Ali ; Shaheen, Faissal ; Al-Ghamdi, Saeed M G ; Al Wakeel, Jamal ; Al Ali, Fadwa ; Al-Aradi, Ali ; Hejaili, Fayez Al ; Maimani, Yacoub Al ; Fouly, Essam ; Robinson, Bruce M ; Pisoni, Ronald L</creatorcontrib><description>The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) has collected data since 2012 in all six Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates). We report the relationship of PTH with mortality in this largest GCC cohort of patients on hemodialysis studied to date.
Data were from randomly selected national samples of hemodialysis facilities in GCC-DOPPS phases 5 and 6 (2012-2018). PTH descriptive findings and case mix-adjusted PTH/mortality Cox regression analyses were based on 1825 and 1422 randomly selected patients on hemodialysis, respectively.
Mean patient age was 55 years (median dialysis vintage, 2.1 years). Median PTH ranged from 259 pg/ml (UAE) to 437 pg/ml (Kuwait), with 22% having PTH <150 pg/ml, 24% with PTH of 150-300 pg/ml, 34% with PTH 301-700 pg/ml, and 20% with PTH >700 pg/ml. Patients with PTH >700 pg/ml were younger; on dialysis longer; less likely to be diabetic; have urine >200 ml/d; be prescribed 3.5 mEq/L dialysate calcium; had higher mean serum creatinine and phosphate levels; lower white blood cell counts; and more likely to be prescribed cinacalcet, phosphate binders, or IV vitamin D. A U-shaped PTH/mortality relationship was observed with more than two- and 1.5-fold higher adjusted HR of death at PTH >700 pg/ml and <300 pg/ml, respectively, compared with PTH of 301-450 pg/ml.
Secondary hyperparathyroidism is highly prevalent among GCC patients on hemodialysis, with a strong U-shaped PTH/mortality relationship seen at PTH <300 and >450 pg/ml. Future studies are encouraged for further understanding this PTH/mortality pattern in relationship to unique aspects of the GCC hemodialysis population.</description><identifier>ISSN: 2641-7650</identifier><identifier>EISSN: 2641-7650</identifier><identifier>DOI: 10.34067/KID.0000772020</identifier><identifier>PMID: 35368779</identifier><language>eng</language><publisher>United States: American Society of Nephrology</publisher><subject>Cohort Studies ; Humans ; Middle Aged ; Original Investigations ; Outcome Assessment, Health Care ; Parathyroid Hormone ; Prospective Studies ; Renal Dialysis - methods</subject><ispartof>Kidney360, 2020-10, Vol.1 (10), p.1083-1090</ispartof><rights>Copyright © 2020 by the American Society of Nephrology.</rights><rights>Copyright © 2020 by the American Society of Nephrology 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c393t-a2f989421bc3bfdb9ec0e8aa45e90a13792c58d28a0e6a0d79ad1d2171424be43</citedby><cites>FETCH-LOGICAL-c393t-a2f989421bc3bfdb9ec0e8aa45e90a13792c58d28a0e6a0d79ad1d2171424be43</cites><orcidid>0000-0002-3443-5972</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815498/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8815498/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35368779$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Al Salmi, Issa</creatorcontrib><creatorcontrib>Bieber, Brian</creatorcontrib><creatorcontrib>Al Rukhaimi, Mona</creatorcontrib><creatorcontrib>AlSahow, Ali</creatorcontrib><creatorcontrib>Shaheen, Faissal</creatorcontrib><creatorcontrib>Al-Ghamdi, Saeed M G</creatorcontrib><creatorcontrib>Al Wakeel, Jamal</creatorcontrib><creatorcontrib>Al Ali, Fadwa</creatorcontrib><creatorcontrib>Al-Aradi, Ali</creatorcontrib><creatorcontrib>Hejaili, Fayez Al</creatorcontrib><creatorcontrib>Maimani, Yacoub Al</creatorcontrib><creatorcontrib>Fouly, Essam</creatorcontrib><creatorcontrib>Robinson, Bruce M</creatorcontrib><creatorcontrib>Pisoni, Ronald L</creatorcontrib><title>Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018)</title><title>Kidney360</title><addtitle>Kidney360</addtitle><description>The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) has collected data since 2012 in all six Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates). We report the relationship of PTH with mortality in this largest GCC cohort of patients on hemodialysis studied to date.
Data were from randomly selected national samples of hemodialysis facilities in GCC-DOPPS phases 5 and 6 (2012-2018). PTH descriptive findings and case mix-adjusted PTH/mortality Cox regression analyses were based on 1825 and 1422 randomly selected patients on hemodialysis, respectively.
Mean patient age was 55 years (median dialysis vintage, 2.1 years). Median PTH ranged from 259 pg/ml (UAE) to 437 pg/ml (Kuwait), with 22% having PTH <150 pg/ml, 24% with PTH of 150-300 pg/ml, 34% with PTH 301-700 pg/ml, and 20% with PTH >700 pg/ml. Patients with PTH >700 pg/ml were younger; on dialysis longer; less likely to be diabetic; have urine >200 ml/d; be prescribed 3.5 mEq/L dialysate calcium; had higher mean serum creatinine and phosphate levels; lower white blood cell counts; and more likely to be prescribed cinacalcet, phosphate binders, or IV vitamin D. A U-shaped PTH/mortality relationship was observed with more than two- and 1.5-fold higher adjusted HR of death at PTH >700 pg/ml and <300 pg/ml, respectively, compared with PTH of 301-450 pg/ml.
Secondary hyperparathyroidism is highly prevalent among GCC patients on hemodialysis, with a strong U-shaped PTH/mortality relationship seen at PTH <300 and >450 pg/ml. Future studies are encouraged for further understanding this PTH/mortality pattern in relationship to unique aspects of the GCC hemodialysis population.</description><subject>Cohort Studies</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Original Investigations</subject><subject>Outcome Assessment, Health Care</subject><subject>Parathyroid Hormone</subject><subject>Prospective Studies</subject><subject>Renal Dialysis - methods</subject><issn>2641-7650</issn><issn>2641-7650</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVkU1v1DAQhiMEolXpmRvysRzS-iuJzQEJbaFbsagrCmdrEk-6Rk68tZNK-0_4uVjbT3zwjDTv-9qjpyjeM3oqJK2bs--X56c0n6bhlNNXxSGvJSubuqKvX_QHxXFKf7KMa86VqN8WB6IStWoafVj8XUOEabOLwVmyDHEII5JrjPNAVniHPhEYLfkR4gTeTTsCWXBDljgE68DvkktkDZPDcUrEjWTaILmYfU8WIWwxJ7sw5n4eO-f3dYoO0yfyE9Pss6WPYdibzq_W62tywinjZb7Ux3fFmx58wuOHelT8_vb112JZrq4uLhdfVmUntJhK4L1WWnLWdqLtbauxo6gAZIWaAhON5l2lLFdAsQZqGw2WWc4aJrlsUYqj4vN97nZuB7Rd3iSCN9voBog7E8CZ_yej25ibcGeUYpXUKgecPATEcDtjmszgUofew4hhTiZzqLWUqhJZenYv7WJIKWL_9AyjZo_UZKTmGWl2fHj5uyf9I0DxD9uGnaI</recordid><startdate>20201029</startdate><enddate>20201029</enddate><creator>Al Salmi, Issa</creator><creator>Bieber, Brian</creator><creator>Al Rukhaimi, Mona</creator><creator>AlSahow, Ali</creator><creator>Shaheen, Faissal</creator><creator>Al-Ghamdi, Saeed M G</creator><creator>Al Wakeel, Jamal</creator><creator>Al Ali, Fadwa</creator><creator>Al-Aradi, Ali</creator><creator>Hejaili, Fayez Al</creator><creator>Maimani, Yacoub Al</creator><creator>Fouly, Essam</creator><creator>Robinson, Bruce M</creator><creator>Pisoni, Ronald L</creator><general>American Society of Nephrology</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-3443-5972</orcidid></search><sort><creationdate>20201029</creationdate><title>Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018)</title><author>Al Salmi, Issa ; Bieber, Brian ; Al Rukhaimi, Mona ; AlSahow, Ali ; Shaheen, Faissal ; Al-Ghamdi, Saeed M G ; Al Wakeel, Jamal ; Al Ali, Fadwa ; Al-Aradi, Ali ; Hejaili, Fayez Al ; Maimani, Yacoub Al ; Fouly, Essam ; Robinson, Bruce M ; Pisoni, Ronald L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c393t-a2f989421bc3bfdb9ec0e8aa45e90a13792c58d28a0e6a0d79ad1d2171424be43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Cohort Studies</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Original Investigations</topic><topic>Outcome Assessment, Health Care</topic><topic>Parathyroid Hormone</topic><topic>Prospective Studies</topic><topic>Renal Dialysis - methods</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Al Salmi, Issa</creatorcontrib><creatorcontrib>Bieber, Brian</creatorcontrib><creatorcontrib>Al Rukhaimi, Mona</creatorcontrib><creatorcontrib>AlSahow, Ali</creatorcontrib><creatorcontrib>Shaheen, Faissal</creatorcontrib><creatorcontrib>Al-Ghamdi, Saeed M G</creatorcontrib><creatorcontrib>Al Wakeel, Jamal</creatorcontrib><creatorcontrib>Al Ali, Fadwa</creatorcontrib><creatorcontrib>Al-Aradi, Ali</creatorcontrib><creatorcontrib>Hejaili, Fayez Al</creatorcontrib><creatorcontrib>Maimani, Yacoub Al</creatorcontrib><creatorcontrib>Fouly, Essam</creatorcontrib><creatorcontrib>Robinson, Bruce M</creatorcontrib><creatorcontrib>Pisoni, Ronald L</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Kidney360</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Al Salmi, Issa</au><au>Bieber, Brian</au><au>Al Rukhaimi, Mona</au><au>AlSahow, Ali</au><au>Shaheen, Faissal</au><au>Al-Ghamdi, Saeed M G</au><au>Al Wakeel, Jamal</au><au>Al Ali, Fadwa</au><au>Al-Aradi, Ali</au><au>Hejaili, Fayez Al</au><au>Maimani, Yacoub Al</au><au>Fouly, Essam</au><au>Robinson, Bruce M</au><au>Pisoni, Ronald L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018)</atitle><jtitle>Kidney360</jtitle><addtitle>Kidney360</addtitle><date>2020-10-29</date><risdate>2020</risdate><volume>1</volume><issue>10</issue><spage>1083</spage><epage>1090</epage><pages>1083-1090</pages><issn>2641-7650</issn><eissn>2641-7650</eissn><abstract>The prospective Dialysis Outcomes and Practice Patterns Study (DOPPS) has collected data since 2012 in all six Gulf Cooperation Council (GCC) countries (Bahrain, Kuwait, Oman, Qatar, Saudi Arabia, and United Arab Emirates). We report the relationship of PTH with mortality in this largest GCC cohort of patients on hemodialysis studied to date.
Data were from randomly selected national samples of hemodialysis facilities in GCC-DOPPS phases 5 and 6 (2012-2018). PTH descriptive findings and case mix-adjusted PTH/mortality Cox regression analyses were based on 1825 and 1422 randomly selected patients on hemodialysis, respectively.
Mean patient age was 55 years (median dialysis vintage, 2.1 years). Median PTH ranged from 259 pg/ml (UAE) to 437 pg/ml (Kuwait), with 22% having PTH <150 pg/ml, 24% with PTH of 150-300 pg/ml, 34% with PTH 301-700 pg/ml, and 20% with PTH >700 pg/ml. Patients with PTH >700 pg/ml were younger; on dialysis longer; less likely to be diabetic; have urine >200 ml/d; be prescribed 3.5 mEq/L dialysate calcium; had higher mean serum creatinine and phosphate levels; lower white blood cell counts; and more likely to be prescribed cinacalcet, phosphate binders, or IV vitamin D. A U-shaped PTH/mortality relationship was observed with more than two- and 1.5-fold higher adjusted HR of death at PTH >700 pg/ml and <300 pg/ml, respectively, compared with PTH of 301-450 pg/ml.
Secondary hyperparathyroidism is highly prevalent among GCC patients on hemodialysis, with a strong U-shaped PTH/mortality relationship seen at PTH <300 and >450 pg/ml. Future studies are encouraged for further understanding this PTH/mortality pattern in relationship to unique aspects of the GCC hemodialysis population.</abstract><cop>United States</cop><pub>American Society of Nephrology</pub><pmid>35368779</pmid><doi>10.34067/KID.0000772020</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-3443-5972</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2641-7650 |
ispartof | Kidney360, 2020-10, Vol.1 (10), p.1083-1090 |
issn | 2641-7650 2641-7650 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8815498 |
source | PubMed (Medline); MEDLINE; DOAJ Directory of Open Access Journals |
subjects | Cohort Studies Humans Middle Aged Original Investigations Outcome Assessment, Health Care Parathyroid Hormone Prospective Studies Renal Dialysis - methods |
title | Parathyroid Hormone Serum Levels and Mortality among Hemodialysis Patients in the Gulf Cooperation Council Countries: Results from the DOPPS (2012-2018) |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T19%3A41%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Parathyroid%20Hormone%20Serum%20Levels%20and%20Mortality%20among%20Hemodialysis%20Patients%20in%20the%20Gulf%20Cooperation%20Council%20Countries:%20Results%20from%20the%20DOPPS%20(2012-2018)&rft.jtitle=Kidney360&rft.au=Al%20Salmi,%20Issa&rft.date=2020-10-29&rft.volume=1&rft.issue=10&rft.spage=1083&rft.epage=1090&rft.pages=1083-1090&rft.issn=2641-7650&rft.eissn=2641-7650&rft_id=info:doi/10.34067/KID.0000772020&rft_dat=%3Cproquest_pubme%3E2646944853%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2646944853&rft_id=info:pmid/35368779&rfr_iscdi=true |